StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

Earnings

MiMedx's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 24, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$62.00M
Adjusted Earnings Per Share, Q3 FY2026
-$0.01
$0.15 a year earlier
Latest guidance
Issued
Oct 28, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of MiMedx's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 24, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 28, 2026after the close$62.00M–-$0.06-$0.01Release
Q2 FY2026ended Jun 30, 2026Jul 29, 2026after the close$64.00M-35.4%––Release
Q1 FY2026ended Mar 31, 2026Apr 29, 2026after the close$59.00M-33.0%-$0.07-$0.05Release
Q4 FY2025ended Dec 31, 2025Feb 25, 2026after the close$118.00M+26.9%$0.10$0.14Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025after the close–––$0.15Release
Q2 FY2025ended Jun 30, 2025Jul 30, 2025after the close$99.00M+13.8%$0.06$0.10Release
Q1 FY2025ended Mar 31, 2025Apr 30, 2025after the close$88.00M+3.5%––Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025after the close$93.00M+6.9%$0.05$0.07Release
Q3 FY2024ended Sep 30, 2024Oct 30, 2024after the close$84.00M+2.8%$0.05$0.07Release
Q2 FY2024ended Jun 30, 2024Jul 31, 2024after the close$87.00M+7.0%$0.12$0.08Release
Q1 FY2024ended Mar 31, 2024Apr 30, 2024after the close$85.00M+18.5%$0.06$0.07Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

MiMedx's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net salesGAAPFY2026$250.00M – $260.00M–NewOct 28, 2026
net salesFY2026$260.00M – $290.00M$260.00M – $290.00MReaffirmedJul 29, 2026

Guidance vs results

The last range MiMedx gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q4 FY2022Revenue$73.00M – $76.00M$74.40MWithin range

Guidance history

Every forecast MiMedx put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 28, 2026net salesFY2026$250.00M – $260.00MNew
Jul 29, 2026net salesFY2026$260.00M – $290.00MReaffirmed
Apr 29, 2026net salesFY2026$260.00M – $290.00MLowered
Feb 25, 2026net salesFY2026$340.00M – $360.00MNew
Jul 30, 2025Adjusted EBITDA marginFY202520%Reaffirmed
Apr 30, 2025Adjusted EBITDA marginFY202520%New
Feb 26, 2025Adjusted EBITDA marginFY202520%New
Oct 30, 2024Adjusted EBITDA marginFY202420%New
Feb 28, 2024Adjusted EBITDA as a percent of net salesFY202420%New
Oct 30, 2023Adjusted EBITDA marginFY202320%Reaffirmed
Oct 30, 2023cash on the balance sheetQ4 FY2023$80.00MNew
Aug 1, 2023Adjusted EBITDA marginFY202320%New
Nov 2, 2022net salesQ4 FY2022$73.00M – $76.00MNew
Nov 2, 2022net salesFY2022$266.00M – $269.00MNew
Aug 2, 2022net sales of its continuing portfolio of Advanced Wound Care productsFY2022+11% – +14%Reaffirmed
May 3, 2022net sales of its continuing portfolio of Advanced Wound Care productsFY2022+11% – +14%Reaffirmed
Feb 28, 2022net sales of its continuing portfolio of productsFY2022+11% – +14%New
Jan 10, 2022R&D spendFY2022$22.00MNew
Jan 10, 2022Net SalesFY2021$254.00M – $259.00MNew
Jan 10, 2022Adjusted Net SalesFY2021$253.00M – $258.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases MiMedx filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Results
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Update
  13. Results
  14. Results
  15. Results

See a number that looks wrong?